chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Disturbance in attention, Electromyogram, Headache
Clinical narrative: I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I have numbness, pins and needle sensations from the elbow to fingers; pins and needle sensations from the elbow to fingers; extreme temperature differences in fingers; loss of strength in arms; extreme sharp pain in both elbows; Bi-lateral ulnar nerve entrapment symptoms; This is a spontaneous report from a contactable other hcp reported for herself. A 39-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EK5730; Expiration date was not reported), via intramuscular, administered in Arm Left on 21Dec2020 10:30 (at the age of 39-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Facility type vaccine was Hospital. The patient was not pregnant at the time of vaccination. Medical history and known allergies included none. Concomitant or other medications in two weeks; other vaccine in four weeks included none. No covid prior vaccination and covid was not tested post vaccination. The patient experienced or started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December), had numbness, pins and needle sensations from the elbow to fingers, extreme temperature differences in fingers, loss of strength in arms, extreme sharp pain in both elbows, bi-lateral ulnar nerve entrapment symptoms on 24Dec2020 15:00. The patient underwent lab tests and procedures which included Electromyogram (EMG) Test), MRI - Cervical and, Nerve Conduction Study (NCS) which showed unknown results on unspecified date. Therapeutic measures were taken as a result of the reported events. AE resulted in Doctor or other healthcare professional office/clinic visit. Patient received treatment for AE with MRI - Cervical, Electromyogram (EMG) Test and Nerve Conduction Study (NCS). Clinical outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging neck, Migraine, Nerve conduction studies, Paraesthesia, Photophobia
Clinical narrative: I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I have numbness, pins and needle sensations from the elbow to fingers; pins and needle sensations from the elbow to fingers; extreme temperature differences in fingers; loss of strength in arms; extreme sharp pain in both elbows; Bi-lateral ulnar nerve entrapment symptoms; This is a spontaneous report from a contactable other hcp reported for herself. A 39-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EK5730; Expiration date was not reported), via intramuscular, administered in Arm Left on 21Dec2020 10:30 (at the age of 39-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Facility type vaccine was Hospital. The patient was not pregnant at the time of vaccination. Medical history and known allergies included none. Concomitant or other medications in two weeks; other vaccine in four weeks included none. No covid prior vaccination and covid was not tested post vaccination. The patient experienced or started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December), had numbness, pins and needle sensations from the elbow to fingers, extreme temperature differences in fingers, loss of strength in arms, extreme sharp pain in both elbows, bi-lateral ulnar nerve entrapment symptoms on 24Dec2020 15:00. The patient underwent lab tests and procedures which included Electromyogram (EMG) Test), MRI - Cervical and, Nerve Conduction Study (NCS) which showed unknown results on unspecified date. Therapeutic measures were taken as a result of the reported events. AE resulted in Doctor or other healthcare professional office/clinic visit. Patient received treatment for AE with MRI - Cervical, Electromyogram (EMG) Test and Nerve Conduction Study (NCS). Clinical outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I have numbness, pins and needle sensations from the elbow to fingers; pins and needle sensations from the elbow to fingers; extreme temperature differences in fingers; loss of strength in arms; extreme sharp pain in both elbows; Bi-lateral ulnar nerve entrapment symptoms; This is a spontaneous report from a contactable other hcp reported for herself. A 39-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EK5730; Expiration date was not reported), via intramuscular, administered in Arm Left on 21Dec2020 10:30 (at the age of 39-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Facility type vaccine was Hospital. The patient was not pregnant at the time of vaccination. Medical history and known allergies included none. Concomitant or other medications in two weeks; other vaccine in four weeks included none. No covid prior vaccination and covid was not tested post vaccination. The patient experienced or started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December), had numbness, pins and needle sensations from the elbow to fingers, extreme temperature differences in fingers, loss of strength in arms, extreme sharp pain in both elbows, bi-lateral ulnar nerve entrapment symptoms on 24Dec2020 15:00. The patient underwent lab tests and procedures which included Electromyogram (EMG) Test), MRI - Cervical and, Nerve Conduction Study (NCS) which showed unknown results on unspecified date. Therapeutic measures were taken as a result of the reported events. AE resulted in Doctor or other healthcare professional office/clinic visit. Patient received treatment for AE with MRI - Cervical, Electromyogram (EMG) Test and Nerve Conduction Study (NCS). Clinical outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Disturbance in attention, Headache, Hypoaesthesia
Clinical narrative: I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I have numbness, pins and needle sensations from the elbow to fingers; pins and needle sensations from the elbow to fingers; extreme temperature differences in fingers; loss of strength in arms; extreme sharp pain in both elbows; Bi-lateral ulnar nerve entrapment symptoms; This is a spontaneous report from a contactable other hcp reported for herself. A 39-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EK5730; Expiration date was not reported), via intramuscular, administered in Arm Left on 21Dec2020 10:30 (at the age of 39-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Facility type vaccine was Hospital. The patient was not pregnant at the time of vaccination. Medical history and known allergies included none. Concomitant or other medications in two weeks; other vaccine in four weeks included none. No covid prior vaccination and covid was not tested post vaccination. The patient experienced or started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December), had numbness, pins and needle sensations from the elbow to fingers, extreme temperature differences in fingers, loss of strength in arms, extreme sharp pain in both elbows, bi-lateral ulnar nerve entrapment symptoms on 24Dec2020 15:00. The patient underwent lab tests and procedures which included Electromyogram (EMG) Test), MRI - Cervical and, Nerve Conduction Study (NCS) which showed unknown results on unspecified date. Therapeutic measures were taken as a result of the reported events. AE resulted in Doctor or other healthcare professional office/clinic visit. Patient received treatment for AE with MRI - Cervical, Electromyogram (EMG) Test and Nerve Conduction Study (NCS). Clinical outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Migraine, Nerve compression, Paraesthesia, Photophobia, Temperature difference of extremities
Clinical narrative: I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December); I have numbness, pins and needle sensations from the elbow to fingers; pins and needle sensations from the elbow to fingers; extreme temperature differences in fingers; loss of strength in arms; extreme sharp pain in both elbows; Bi-lateral ulnar nerve entrapment symptoms; This is a spontaneous report from a contactable other hcp reported for herself. A 39-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EK5730; Expiration date was not reported), via intramuscular, administered in Arm Left on 21Dec2020 10:30 (at the age of 39-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Facility type vaccine was Hospital. The patient was not pregnant at the time of vaccination. Medical history and known allergies included none. Concomitant or other medications in two weeks; other vaccine in four weeks included none. No covid prior vaccination and covid was not tested post vaccination. The patient experienced or started having migraine issues (no prior history) intense pain in the head, sensitive to light, blurred vision, and not able to concentrate (December), had numbness, pins and needle sensations from the elbow to fingers, extreme temperature differences in fingers, loss of strength in arms, extreme sharp pain in both elbows, bi-lateral ulnar nerve entrapment symptoms on 24Dec2020 15:00. The patient underwent lab tests and procedures which included Electromyogram (EMG) Test), MRI - Cervical and, Nerve Conduction Study (NCS) which showed unknown results on unspecified date. Therapeutic measures were taken as a result of the reported events. AE resulted in Doctor or other healthcare professional office/clinic visit. Patient received treatment for AE with MRI - Cervical, Electromyogram (EMG) Test and Nerve Conduction Study (NCS). Clinical outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19, FLU4, COVID19
Symptoms: Abdominal pain upper, Malaise
Clinical narrative: stomach cramps unless I have a lot on my stomach; occasional nausea; general malaise; This is a spontaneous report from a contactable consumer (patient). A 75-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: FC3182, patient was 75-year-old and not pregnant at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 25Aug2021 at 13:00 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included mainly chronic pain, low thyroid, Prolia for osteoporosis, sinusitis. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN 81); famotidine (FAMOTIDINE); gabapentin (GABAPENTIN) all were taken for an unspecified indication within two weeks, start and stop date were not reported; influenza vaccine (INFLUENZA VACCINE) taken for influenza from 20Aug2021 to 20Aug2021, administered in Right Left within four weeks. No Covid prior vaccination, it was unknown If Covid tested post vaccination, no Known allergies. On 28Aug2021 at 01:00 AM, the patient experienced stomach cramps unless i have a lot on my stomach, occasional nausea, general malaise. Patient did not received treatment for events. The outcomes of events were recovering.  Follow-Up (08Sep2021): Follow-up attempts are completed. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19, FLU4, COVID19
Symptoms: Abdominal pain upper, Malaise, Nausea
Clinical narrative: stomach cramps unless I have a lot on my stomach; occasional nausea; general malaise; This is a spontaneous report from a contactable consumer (patient). A 75-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: FC3182, patient was 75-year-old and not pregnant at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 25Aug2021 at 13:00 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included mainly chronic pain, low thyroid, Prolia for osteoporosis, sinusitis. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN 81); famotidine (FAMOTIDINE); gabapentin (GABAPENTIN) all were taken for an unspecified indication within two weeks, start and stop date were not reported; influenza vaccine (INFLUENZA VACCINE) taken for influenza from 20Aug2021 to 20Aug2021, administered in Right Left within four weeks. No Covid prior vaccination, it was unknown If Covid tested post vaccination, no Known allergies. On 28Aug2021 at 01:00 AM, the patient experienced stomach cramps unless i have a lot on my stomach, occasional nausea, general malaise. Patient did not received treatment for events. The outcomes of events were recovering.  Follow-Up (08Sep2021): Follow-up attempts are completed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction, Muscle spasms, Muscle twitching, Pain in extremity, Paraesthesia
Clinical narrative: continuous really weird muscle twitching; This is a spontaneous report from a contactable consumer (patient herself). A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0185) via an unspecified route of administration, administered in left arm on 27Aug2021 (at the age of 50-years) as dose 2, single for COVID-19 immunization (pharmacy). The patient medical history included none. The patient concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0217) via an unspecified route of administration on 06Aug2021 as dose 1, single for COVID-19 immunization. Reporter stated that after the 2nd dose of the vaccination, that night she had continuous really weird muscle twitching and queried if the muscle twitching was a side effect of the vaccine. She also stated that she never had muscle twitching before in her entire life and now had muscle twitching. The reporter stated that, the muscle twitching had started within 12 hours of vaccination and she was sleeping that night and first noticed the first twitching in her whole upper back muscle and last night it was in her arm and during the day it was in her leg and was kind of all over in her body and not too long ago it was twitching in her chest muscle and is going on everywhere and is very sporadic. She also stated that happens and lasts several minutes and then goes away but was ongoing and the same as when it began. The outcome of the event was not recovered.   Follow-up attempts are completed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder
Clinical narrative: continuous really weird muscle twitching; This is a spontaneous report from a contactable consumer (patient herself). A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0185) via an unspecified route of administration, administered in left arm on 27Aug2021 (at the age of 50-years) as dose 2, single for COVID-19 immunization (pharmacy). The patient medical history included none. The patient concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0217) via an unspecified route of administration on 06Aug2021 as dose 1, single for COVID-19 immunization. Reporter stated that after the 2nd dose of the vaccination, that night she had continuous really weird muscle twitching and queried if the muscle twitching was a side effect of the vaccine. She also stated that she never had muscle twitching before in her entire life and now had muscle twitching. The reporter stated that, the muscle twitching had started within 12 hours of vaccination and she was sleeping that night and first noticed the first twitching in her whole upper back muscle and last night it was in her arm and during the day it was in her leg and was kind of all over in her body and not too long ago it was twitching in her chest muscle and is going on everywhere and is very sporadic. She also stated that happens and lasts several minutes and then goes away but was ongoing and the same as when it began. The outcome of the event was not recovered.   Follow-up attempts are completed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle twitching
Clinical narrative: continuous really weird muscle twitching; This is a spontaneous report from a contactable consumer (patient herself). A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0185) via an unspecified route of administration, administered in left arm on 27Aug2021 (at the age of 50-years) as dose 2, single for COVID-19 immunization (pharmacy). The patient medical history included none. The patient concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0217) via an unspecified route of administration on 06Aug2021 as dose 1, single for COVID-19 immunization. Reporter stated that after the 2nd dose of the vaccination, that night she had continuous really weird muscle twitching and queried if the muscle twitching was a side effect of the vaccine. She also stated that she never had muscle twitching before in her entire life and now had muscle twitching. The reporter stated that, the muscle twitching had started within 12 hours of vaccination and she was sleeping that night and first noticed the first twitching in her whole upper back muscle and last night it was in her arm and during the day it was in her leg and was kind of all over in her body and not too long ago it was twitching in her chest muscle and is going on everywhere and is very sporadic. She also stated that happens and lasts several minutes and then goes away but was ongoing and the same as when it began. The outcome of the event was not recovered.   Follow-up attempts are completed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthritis, Gait disturbance, Joint stiffness, Neurological symptom, Paraesthesia
Clinical narrative: Pt. states that after receiving the 1st dose of J&J 07/21/2021, started experiencing symptoms 08/15/2021 of extreme pain in the knees (both), *Both knees replacement '18 & 04/13/2021. Left hand joint pain difficulty closing. Scheduled MRI 09/22/2021. Prior X-Rays preformed and no indications of injury (unknown source). Still continuing to experience symptoms.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, X-ray
Clinical narrative: Pt. states that after receiving the 1st dose of J&J 07/21/2021, started experiencing symptoms 08/15/2021 of extreme pain in the knees (both), *Both knees replacement '18 & 04/13/2021. Left hand joint pain difficulty closing. Scheduled MRI 09/22/2021. Prior X-Rays preformed and no indications of injury (unknown source). Still continuing to experience symptoms.
Age: 94.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Epistaxis
Clinical narrative: MOUTH ULCER
Age: 94.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mouth ulceration
Clinical narrative: MOUTH ULCER
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anaemia, COVID-19, Chest X-ray abnormal, Chronic kidney disease, Cough
Clinical narrative: ****This is an addendum to VAERS report #634488 Previous report included lot numbers, background info, and hospitalization for COVID.  This addendum is to report that patient died 9/22/2021 from COVID related complications.  Hospital course:  Patient admitted with COVID pneumonia and treated for same.  Course was complicated by Stenotrophomonas pneumonia and C diff colitis.  He was gradually improving and down to 3-5 liters of oxygen by nasal cannula.  He was considering transitioning to comfort cares after discharge.  On morning of 9/21 he had abrupt loss of consciousness.  Intubated for airway protection and brought to ICU.  CT showed large intracranial hemorrhage.  Neurosurgery consulted and advised against surgical intervention and recommended discussion with palliative care.  Discussed goals of care with son who confirmed that patient would not want continued support under these circumstances.  Support was withdrawn and he passed peacefully at 8:39 am on 9/22/2021.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Dyspnoea, Lung opacity, Oxygen saturation decreased, Pneumonia
Clinical narrative: ****This is an addendum to VAERS report #634488 Previous report included lot numbers, background info, and hospitalization for COVID.  This addendum is to report that patient died 9/22/2021 from COVID related complications.  Hospital course:  Patient admitted with COVID pneumonia and treated for same.  Course was complicated by Stenotrophomonas pneumonia and C diff colitis.  He was gradually improving and down to 3-5 liters of oxygen by nasal cannula.  He was considering transitioning to comfort cares after discharge.  On morning of 9/21 he had abrupt loss of consciousness.  Intubated for airway protection and brought to ICU.  CT showed large intracranial hemorrhage.  Neurosurgery consulted and advised against surgical intervention and recommended discussion with palliative care.  Discussed goals of care with son who confirmed that patient would not want continued support under these circumstances.  Support was withdrawn and he passed peacefully at 8:39 am on 9/22/2021.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Traumatic lung injury
Clinical narrative: ****This is an addendum to VAERS report #634488 Previous report included lot numbers, background info, and hospitalization for COVID.  This addendum is to report that patient died 9/22/2021 from COVID related complications.  Hospital course:  Patient admitted with COVID pneumonia and treated for same.  Course was complicated by Stenotrophomonas pneumonia and C diff colitis.  He was gradually improving and down to 3-5 liters of oxygen by nasal cannula.  He was considering transitioning to comfort cares after discharge.  On morning of 9/21 he had abrupt loss of consciousness.  Intubated for airway protection and brought to ICU.  CT showed large intracranial hemorrhage.  Neurosurgery consulted and advised against surgical intervention and recommended discussion with palliative care.  Discussed goals of care with son who confirmed that patient would not want continued support under these circumstances.  Support was withdrawn and he passed peacefully at 8:39 am on 9/22/2021.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Clostridium difficile colitis, Computerised tomogram head abnormal, Death, Endotracheal intubation
Clinical narrative: ****This is an addendum to VAERS report #634488 Previous report included lot numbers, background info, and hospitalization for COVID.  This addendum is to report that patient died 9/22/2021 from COVID related complications.  Hospital course:  Patient admitted with COVID pneumonia and treated for same.  Course was complicated by Stenotrophomonas pneumonia and C diff colitis.  He was gradually improving and down to 3-5 liters of oxygen by nasal cannula.  He was considering transitioning to comfort cares after discharge.  On morning of 9/21 he had abrupt loss of consciousness.  Intubated for airway protection and brought to ICU.  CT showed large intracranial hemorrhage.  Neurosurgery consulted and advised against surgical intervention and recommended discussion with palliative care.  Discussed goals of care with son who confirmed that patient would not want continued support under these circumstances.  Support was withdrawn and he passed peacefully at 8:39 am on 9/22/2021.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemorrhage intracranial, Intensive care, Loss of consciousness, Pneumonia
Clinical narrative: ****This is an addendum to VAERS report #634488 Previous report included lot numbers, background info, and hospitalization for COVID.  This addendum is to report that patient died 9/22/2021 from COVID related complications.  Hospital course:  Patient admitted with COVID pneumonia and treated for same.  Course was complicated by Stenotrophomonas pneumonia and C diff colitis.  He was gradually improving and down to 3-5 liters of oxygen by nasal cannula.  He was considering transitioning to comfort cares after discharge.  On morning of 9/21 he had abrupt loss of consciousness.  Intubated for airway protection and brought to ICU.  CT showed large intracranial hemorrhage.  Neurosurgery consulted and advised against surgical intervention and recommended discussion with palliative care.  Discussed goals of care with son who confirmed that patient would not want continued support under these circumstances.  Support was withdrawn and he passed peacefully at 8:39 am on 9/22/2021.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, Chest pain, Echocardiogram normal, Electrocardiogram normal, Troponin increased
Clinical narrative: Myocarditis and Pericarditis. Hospitalized for 5 days.; Myocarditis and Pericarditis. Hospitalized for 5 days.; Cannot get my heart rate above a slow walk and cannot play my senior season for D1 college sport.; This is a spontaneous report from a contactable consumer (patient). A 21-year-old male patient reported for himself that he received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: FC3182), via an unspecified route of administration, administered in arm left on 31Aug2021 at 06:30 PM (age at vaccination was 21-years-old) as DOSE 2, SINGLE for covid-19 immunisation at pharmacy or drug store. Medical history included known allergies to penicillin from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was tested for COVID-19. There were no concomitant medications. The patient previously took bnt162b2 (Bath/Lot Number: FC3181), via an unspecified route of administration, administered in arm left on 10Aug2021 at 03:15 PM (age at vaccination was 21-years-old) as DOSE 1, SINGLE for covid-19 immunisation. No other vaccines were received within four weeks prior to the administration of bnt162b2. No other medications the patient received within 2 weeks of vaccination. On 03Sep2021 at 11:00 PM, the patient experienced myocarditis and pericarditis and was hospitalized for 5 days. The patient could not get his heart rate above a slow walk and could not play his senior season for D1 college sport. The events resulted in emergency room/department or urgent care. The seriousness criteria for events was assessed as hospitalization and life-threatening. On 04Sep2021, the patient underwent covid test post vaccination with covid test type nasal swab: negative. Therapeutic measures were taken as a result of the events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cardiac disorder, Myocarditis, Pericarditis
Clinical narrative: Myocarditis and Pericarditis. Hospitalized for 5 days.; Myocarditis and Pericarditis. Hospitalized for 5 days.; Cannot get my heart rate above a slow walk and cannot play my senior season for D1 college sport.; This is a spontaneous report from a contactable consumer (patient). A 21-year-old male patient reported for himself that he received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: FC3182), via an unspecified route of administration, administered in arm left on 31Aug2021 at 06:30 PM (age at vaccination was 21-years-old) as DOSE 2, SINGLE for covid-19 immunisation at pharmacy or drug store. Medical history included known allergies to penicillin from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was tested for COVID-19. There were no concomitant medications. The patient previously took bnt162b2 (Bath/Lot Number: FC3181), via an unspecified route of administration, administered in arm left on 10Aug2021 at 03:15 PM (age at vaccination was 21-years-old) as DOSE 1, SINGLE for covid-19 immunisation. No other vaccines were received within four weeks prior to the administration of bnt162b2. No other medications the patient received within 2 weeks of vaccination. On 03Sep2021 at 11:00 PM, the patient experienced myocarditis and pericarditis and was hospitalized for 5 days. The patient could not get his heart rate above a slow walk and could not play his senior season for D1 college sport. The events resulted in emergency room/department or urgent care. The seriousness criteria for events was assessed as hospitalization and life-threatening. On 04Sep2021, the patient underwent covid test post vaccination with covid test type nasal swab: negative. Therapeutic measures were taken as a result of the events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Heart rate abnormal, Myocarditis, Pericarditis, SARS-CoV-2 test
Clinical narrative: Myocarditis and Pericarditis. Hospitalized for 5 days.; Myocarditis and Pericarditis. Hospitalized for 5 days.; Cannot get my heart rate above a slow walk and cannot play my senior season for D1 college sport.; This is a spontaneous report from a contactable consumer (patient). A 21-year-old male patient reported for himself that he received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: FC3182), via an unspecified route of administration, administered in arm left on 31Aug2021 at 06:30 PM (age at vaccination was 21-years-old) as DOSE 2, SINGLE for covid-19 immunisation at pharmacy or drug store. Medical history included known allergies to penicillin from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was tested for COVID-19. There were no concomitant medications. The patient previously took bnt162b2 (Bath/Lot Number: FC3181), via an unspecified route of administration, administered in arm left on 10Aug2021 at 03:15 PM (age at vaccination was 21-years-old) as DOSE 1, SINGLE for covid-19 immunisation. No other vaccines were received within four weeks prior to the administration of bnt162b2. No other medications the patient received within 2 weeks of vaccination. On 03Sep2021 at 11:00 PM, the patient experienced myocarditis and pericarditis and was hospitalized for 5 days. The patient could not get his heart rate above a slow walk and could not play his senior season for D1 college sport. The events resulted in emergency room/department or urgent care. The seriousness criteria for events was assessed as hospitalization and life-threatening. On 04Sep2021, the patient underwent covid test post vaccination with covid test type nasal swab: negative. Therapeutic measures were taken as a result of the events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Lip swelling, Pharyngeal swelling, Swollen tongue
Clinical narrative: 20 minutes after receiving the shot my tongue got tingly, then spread to my lips, and right side of my jaw line. The my left arm felt numb and tingly. I had a metallic taste in my mouth. It felt like I had something stuck in my throat. I felt dizzy and lightheaded with some confusion. I also felt like I couldn?t take a deep breath. All of this happened after I left the vaccine bus. When I arrived back home I took Benadryl the symptoms eased up but did not go away. The next day I went to the doctor I still had swelling in my throat, couldn?t take a deep breath, lips and tongue were still numb and tingly. I went to the ER that night which would have been a little after 24 hours after the first symptoms. I felt like I couldn?t take a deep breath, lips and tongue were still tingly and numb, felt like my throat was still tight, and felt confusion and lightheaded again. I ended up taking 40 milligrams of prednisone, Claritin, and Pepcid for 3 days. After the three days I continued the Pepcid and claritin. These symptoms were still present that following Tuesday 5 days later. I followed up with my doctor.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Dizziness, Dysgeusia, Dyspnoea, Oropharyngeal discomfort
Clinical narrative: 20 minutes after receiving the shot my tongue got tingly, then spread to my lips, and right side of my jaw line. The my left arm felt numb and tingly. I had a metallic taste in my mouth. It felt like I had something stuck in my throat. I felt dizzy and lightheaded with some confusion. I also felt like I couldn?t take a deep breath. All of this happened after I left the vaccine bus. When I arrived back home I took Benadryl the symptoms eased up but did not go away. The next day I went to the doctor I still had swelling in my throat, couldn?t take a deep breath, lips and tongue were still numb and tingly. I went to the ER that night which would have been a little after 24 hours after the first symptoms. I felt like I couldn?t take a deep breath, lips and tongue were still tingly and numb, felt like my throat was still tight, and felt confusion and lightheaded again. I ended up taking 40 milligrams of prednisone, Claritin, and Pepcid for 3 days. After the three days I continued the Pepcid and claritin. These symptoms were still present that following Tuesday 5 days later. I followed up with my doctor.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Pharyngeal swelling
Clinical narrative: 20 minutes after receiving the shot my tongue got tingly, then spread to my lips, and right side of my jaw line. The my left arm felt numb and tingly. I had a metallic taste in my mouth. It felt like I had something stuck in my throat. I felt dizzy and lightheaded with some confusion. I also felt like I couldn?t take a deep breath. All of this happened after I left the vaccine bus. When I arrived back home I took Benadryl the symptoms eased up but did not go away. The next day I went to the doctor I still had swelling in my throat, couldn?t take a deep breath, lips and tongue were still numb and tingly. I went to the ER that night which would have been a little after 24 hours after the first symptoms. I felt like I couldn?t take a deep breath, lips and tongue were still tingly and numb, felt like my throat was still tight, and felt confusion and lightheaded again. I ended up taking 40 milligrams of prednisone, Claritin, and Pepcid for 3 days. After the three days I continued the Pepcid and claritin. These symptoms were still present that following Tuesday 5 days later. I followed up with my doctor.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bell's palsy
Clinical narrative: Bells Palsy (right side of face); This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received the second dose of bnt162b2 (BNT162B2, Lot Number: FC3180), via an unspecified route of administration, administered in Arm Left on 26Aug2021 13:45 (at the age of 33-years-old) as DOSE 2, SINGLE for COVID-19 immunisation. The vaccine was administered at a pharmacy of drug store. The patient did not receive any other vaccine in four weeks prior to receiving bnt162b2. Medical history was reported as none. The patient had no known allergies. The patient was not pregnant and had no covid prior to vaccination. There were no concomitant medications. The patient previously received the first dose of bnt162b2 (BNT162B2, Lot Number: FA6780), via an unspecified route of administration, administered in Arm Left on 05Aug2021 13:45 (at the age of 33-years-old) for COVID-19 immunisation. The patient experienced bells palsy (right side of face) on 01Sep2021 07:00. Therapeutic measures were taken as a result of the event which included steroids. Outcome of the event was not recovered. The adverse event resulted into Doctor or other healthcare professional office/clinic visit, disability or permanent damage. The patient was tested for covid via Nasal Swab on 02Sep2021 and had a negative result.  No follow-up attempts are not needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bell's palsy, SARS-CoV-2 test
Clinical narrative: Bells Palsy (right side of face); This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received the second dose of bnt162b2 (BNT162B2, Lot Number: FC3180), via an unspecified route of administration, administered in Arm Left on 26Aug2021 13:45 (at the age of 33-years-old) as DOSE 2, SINGLE for COVID-19 immunisation. The vaccine was administered at a pharmacy of drug store. The patient did not receive any other vaccine in four weeks prior to receiving bnt162b2. Medical history was reported as none. The patient had no known allergies. The patient was not pregnant and had no covid prior to vaccination. There were no concomitant medications. The patient previously received the first dose of bnt162b2 (BNT162B2, Lot Number: FA6780), via an unspecified route of administration, administered in Arm Left on 05Aug2021 13:45 (at the age of 33-years-old) for COVID-19 immunisation. The patient experienced bells palsy (right side of face) on 01Sep2021 07:00. Therapeutic measures were taken as a result of the event which included steroids. Outcome of the event was not recovered. The adverse event resulted into Doctor or other healthcare professional office/clinic visit, disability or permanent damage. The patient was tested for covid via Nasal Swab on 02Sep2021 and had a negative result.  No follow-up attempts are not needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris, Chest pain, Pain
Clinical narrative: feel a pinch or prick type of pain in my heart; This is a spontaneous report from a contactable consumer (reported for herself). A 76-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 09Aug2021 14:00 (at the age of 76-year-old) (Lot Number: END172) as dose 1, single for COVID-19 immunisation. Medical history included hereditary hemorrhagic telangiectasia (HHT). Concomitant medications included fish oil (OMEGA 3), ascorbic acid (VIT C), vitamin b, and glucosamine; all taken for unspecified indications, start and stop date were not reported (medications the patient received within 2 weeks of vaccination). On 13Aug2021, four days after the first shot, she began to feel a pinch or prick type of pain in her heart, which then radiated and slowly dissipated. The whole process took about a couple of minutes or a bit more. This happened several times a day, without a definite interval, for about 4 or 5 days. It didn't happen again. She wanted to go to urgent care but decided not to go. After inquiring in the hospital pharmacy, they suggested that she report it. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. No treatment was received for the event. The outcome of the event was recovered on an unspecified date in Aug2021. The reported event was assessed as non-serious.  Follow-up attempts are completed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris
Clinical narrative: feel a pinch or prick type of pain in my heart; This is a spontaneous report from a contactable consumer (reported for herself). A 76-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 09Aug2021 14:00 (at the age of 76-year-old) (Lot Number: END172) as dose 1, single for COVID-19 immunisation. Medical history included hereditary hemorrhagic telangiectasia (HHT). Concomitant medications included fish oil (OMEGA 3), ascorbic acid (VIT C), vitamin b, and glucosamine; all taken for unspecified indications, start and stop date were not reported (medications the patient received within 2 weeks of vaccination). On 13Aug2021, four days after the first shot, she began to feel a pinch or prick type of pain in her heart, which then radiated and slowly dissipated. The whole process took about a couple of minutes or a bit more. This happened several times a day, without a definite interval, for about 4 or 5 days. It didn't happen again. She wanted to go to urgent care but decided not to go. After inquiring in the hospital pharmacy, they suggested that she report it. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. No treatment was received for the event. The outcome of the event was recovered on an unspecified date in Aug2021. The reported event was assessed as non-serious.  Follow-up attempts are completed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Laboratory test, Limb discomfort, Ultrasound Doppler abnormal
Clinical narrative: I developed a DVT in my right leg in the days following the vaccination. I have never had this symptom before and blood tests indicated I was not genetically predisposed to have clots
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Deep vein thrombosis
Clinical narrative: I developed a DVT in my right leg in the days following the vaccination. I have never had this symptom before and blood tests indicated I was not genetically predisposed to have clots